Clinical Trial Update: Effect of Thrombolysis on 30-day Mortality in Intermediate High Risk Pulmonary Patients With Low Bleeding Risk [NA]

View source ↗

Summary

A completed clinical trial evaluating whether thrombolysis affects 30-day mortality in patients with intermediate-high risk pulmonary embolism and low bleeding …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Embolism

Snippet

Sponsor: Ain Shams University | Conditions: Pulmonary Embolism Subacute Massive, Thrombolytic Therapy | NA | Status: COMPLETED